ANTIPROLIFERATIVE ACTIVITIES Of EXTRACTS FROM MYCELIAL BIOMASS OF SOME MEDICINAL BASIDIOMYCETES IN HUMAN COLON CANCER CELLS COLO 205

Authors

  • L.V. Garmanchuk ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv
  • N.P. Vedenicheva M.G. Kholodny Institute of Botany
  • G.A. Al-Maali M.G. Kholodny Institute of Botany
  • D.I. Ostapchenko ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv
  • Yu.V. Tseyslyer ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv
  • V.A. Liashenko ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv
  • N.A. Bisko M.G. Kholodny Institute of Botany
  • I.V. Kosakivska M.G. Kholodny Institute of Botany
  • L.I. Ostapchenko ESC “Institute of Biology and Medicine”, Taras Shevchenko National University of Kyiv

DOI:

https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18434

Keywords:

antiproliferative effect, cytokinins, human colon cancer, medicinal mushrooms

Abstract

Background: The anticancer effects of phytohormones of cytokinin nature are similar to those of medicinal mushrooms, which are able to synthesize cytokinins in large amounts. Aim: To determine the antiproliferative effect of crude extracts and cytokinin fractions from the mycelial biomass of seven fungi species on colon cancer cells in vitro. Materials and Methods: Cytokinin content in mycelial biomass of Ganoderma lucidum, Lentinula edodes, Trametes versicolor, Pleurotus ostreatus, Morchella esculenta, Hericium coralloides, and Fomitopsis officinalis was determined by high performance liquid chromatography mass spectrometry. The antiproliferative effect of the mushroom extracts on the human colon adenocarcinoma Colo 205 cells was assessed by MTT-test. Results: The content of cytokinins (trans-zeatin, zeatin riboside, isopentenyladenosine, isopentenyladenine and zeatin-O-glucoside) was determined in the mycelial biomass of the medicinal macromycetes. Zeatin-type hormones prevailed in all species, though trans-zeatin was the most abundant in H. coralloides and M. esculenta. In P. ostreatus, only zeatin-O-glucoside was detected. The lowest IC50 was found for both the cytokinin fraction (0.21 μg/ml) and the crude extract (0.17 μg/ml) from mycelial biomass of H. coralloides. F. officinalis also demonstrated high antiproliferative effect against Colo 205 cells: IC50 was 0.9 μg/ml for the crude extract and almost twice lower for the cytokinin fraction. In the studied concentration range (0.016–2 μg/ml), the crude extracts from G. lucidum and M. esculenta and the cytokinin fraction from L. edodes did not reach IC50 values. Conclusions: The present study showed that crude extracts and/or cytokinin fractions of several medicinal Basidiomycetes species are capable to inhibit proliferation of colon cancer cells in vitro. Crude extract cytotoxicity of H. coralloides, P. ostreatus and T. versicolor was higher than that of cytokinin fraction while antiproliferative effect of cytokinin fraction from F. officinalis was higher than that in its crude extract.

References

Chang ST, Wasser SP. Current and future research trends in agricultural and biomedicial applications of medicinal mushrooms and mushroom products. Int J Med Mushrooms 2018; 20: 1121–33. https://doi.org/10.1615/IntJMedMushrooms.2018029378

Blagodatski A, Yatsunskaya M, Mikhailova V, et al. Medicinal mushrooms as an attractive new source of natural compounds for future cancer therapy. Oncotarget 2018; 9: 29259–74. https://doi.org/10.18632/oncotarget.25660

Zmitrovich IV, Belova NV, Balandaykin ME, et al. Cancer without pharmacological illusions and a niche for mycotherapy (review). Int J Med Mushrooms 2019; 21: 105–19. https://doi.org/10.1615/IntJMedMushrooms.2019030047

Wasser SP. Medicinal mushrooms in human clinical studies. Part I. Anticancer, oncoimmunological and immunomodulatory activities: A review. Int J Med Mushrooms 2017; 19: 279–317. https://doi.org/10.1615/IntJMedMushrooms.v19.i4.10

Voller J, Zatloukal M, Lenobel R, et al. Anticancer activity of natural cytokinins: A structure–activity relationship study. Phytochem 2010; 71: 1350–59. https://doi.org/10.1016/j.phytochem.2010.04.018

Drenichev MS, Oslovsky VE, Mikhailov SN. Cytokinin nucleosides — natural compounds with a unique spectrum of biological activities. Curr Top Med Chem 2016; 16: 2562–76. https://doi.org/10.2174/1568026616666160414123717

Vedenicheva NP, Kosakivska IV. Cytokinins in fungi. Bull Khark Nac Agrar Univ, Ser Biol 2020; 2: 54–69 (in Russian). https://doi.org/10.35550/vbio2020.02.054

Vedenicheva NP, Al-Maali GA, Bisko NA, et al. Effect of cytokinin-containing extracts from some medicinal mushroom mycelia on HepG2 cells in vitro. Int J Med Mushrooms 2021; 23: 15 – 28. https://doi.org/10.1615/IntJMedMushrooms.2021037656

Vedenicheva N, Al-Maali G, Bisko N, et al. Effect of bioactive extracts with high cytokinin content from micelial biomass of Hericium coralloides and Fomitopsis officinalis on tumor cells in vitro. Bull Taras Shevchenko Nat Univ Kyiv — Biology 2019; 79: 31–7.

Zangiacomi V, Kenichi U, Koji M, et al. CD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile. Genes Cancer 2014; 5: 250–60. https://doi.org/10.18632/genesandcancer.23

Li CY, Li BX, Liang Y, et al. Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB. J Transl Med 2009; 7: 56. https://doi.org/10.1186/1479-5876-7-56

Zhang Q, Shi S, Yen Y, et al. A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Lett 2010; 289: 151–60. https://doi.org/10.1016/j.canlet.2009.08.010

Bisko NA, Lomberg ML, Mytropolska NYu, Mykchaylova OB. The IBK Mushroom Culture Collection. Kyiv: M.G. Kholodny Institute of Botany, National Academy of Sciences of Ukraine. Kyiv: Alterpres, 2016. 120 p.

Vedenicheva NP, Al-Maali GA, Mytropolska NYu, et al. Endogenous cytokinins in medicinal basidiomycetes mycelial biomass. Biotechnol Acta 2016; 9: 55–63. https://doi.org/10.15407/biotech9.01.055

Semple TU, Quinn LA, Woods LK, Moore GE. Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res 1978; 38: 1345–55.PMID 565251

Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55–63.

Alley MC, Scudiero DA, Monks A, Hursey ML, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988, 48: 589−601.

Voller J, Béres T, Zatloukal M, et al. Anti-cancer activities of cytokinin ribosides. Phytochem Rev 2019; 18: 1101–13. https://doi.org/10.1007/s11101-019-09620-4

Chopra H, Mishra AK, Baig AA, et al. Narrative review: bioactive potential of various mushrooms as the treasure of versatile therapeutic natural product. J Fungi 2021; 7: 728. https://doi.org/10.3390/jof7090728

Panda SK, Sahoo G, Swain SS, Luyten W. Anticancer activities of mushrooms: a neglected source for drug discovery. Pharmaceuticals 2022; 15: 176. https://doi.org/10.3390/ph15020176

Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: A review of scientific evidence. Nutr Cancer 2005; 53: 11–7. https://doi.org/10.1207/s15327914nc5301_2

Shin MS, Park H-J, Maeda T, et al. The effects of AHCC®, a standardized extract of cultured Lentinura edodes mycelia, on natural killer and T cells in health and disease: reviews on human and animal studies. J Immunol Res 2019; 2019: 3758576. https://doi.org/10.1155/2019/3758576

Dou H, Chang Y, Zhang L. Coriolus versicolor polysaccharopeptide as an immunotherapeutic in China. Prog Mol Biol Transl Sci 2019; 163: 361–81. https://doi.org/10.1016/bs.pmbts.2019.03.001

Cao X, Liu J, Yang W, et al. Antitumor activity of polysaccharide extracted from Pleurotus ostreatus mycelia against gastric cancer in vitro and in vivo. Mol Med Rep 2015; 12: 2383–9. https://doi.org/10.3892/mmr.2015.3648

Ebrahimi A, Atashi A, Soleimani M, et al. Comparison of anticancer effect of Pleurotus ostreatus extract with doxorubicin hydrochloride alone and plus thermotherapy on erythroleukemia cell line. J Compl Integr Med 2018; 15: 20160136. https://doi.org/10.1515/jcim-2016-0136

Wu H, Chen J, Li J, et al. Recent advances on bioactive ingredients of Morchella esculenta. Appl Biochem Biotechnol 2021; 193: 4197–213. https://doi.org/10.1007/s12010-021-03670-1

Downloads

Published

26.05.2023

How to Cite

Garmanchuk, L., Vedenicheva, N., Al-Maali, G., Ostapchenko, D., Tseyslyer, Y., Liashenko, V., … Ostapchenko, L. (2023). ANTIPROLIFERATIVE ACTIVITIES Of EXTRACTS FROM MYCELIAL BIOMASS OF SOME MEDICINAL BASIDIOMYCETES IN HUMAN COLON CANCER CELLS COLO 205. Experimental Oncology, 44(3), 213–216. https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18434

Issue

Vol. 44 No. 3 (2022): Experimental Oncology

Section

Original contributions

License

Copyright (c) 2023 Experimental Oncology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)